Royal Bio-Pharmaceutical Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

Royal Bio-Pharmaceutical General Information


Developer of vaccines. The company develops and produces biopharmaceuticals including therapeutic and preventive products, and biological reagents.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Corporate Office
  • No.32, Changjiang South Road
  • Wuxi National High-tech Industrial Development Zone
  • Wuxi, Jiangsu 214028
  • China
+86 0510 0000 0000 000. 0000

Royal Bio-Pharmaceutical Timeline

Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Royal Bio-Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 06-Sep-2021 000.00 Completed Profitable
6. Later Stage VC 22-Jul-2021 000.00 000.00 00000 Completed Profitable
5. Merger/Acquisition 24-Apr-2020 00000 00000 Cancelled Profitable
4. Secondary Transaction - Private 26-Nov-2018 00.000 Completed Profitable
3. Secondary Transaction - Private 31-Jan-2018 00.000 Completed Profitable
2. Later Stage VC (Series B) 01-Feb-2013 $3.93M Completed Generating Revenue
1. Later Stage VC (Series A) 14-Jun-2012 $3.93M $3.93M Completed Generating Revenue
To view Royal Bio-Pharmaceutical’s complete valuation and funding history, request access »

Royal Bio-Pharmaceutical Executive Team (1)

Name Title Board Seat Contact Info
Xuanhong Chen General Manager & Chairman
To view Royal Bio-Pharmaceutical’s complete executive team members history, request access »

Royal Bio-Pharmaceutical Board Members (2)

Name Representing Role Since
Linzai Du Royal Bio-Pharmaceutical Board Member 000 0000
Xuanhong Chen Royal Bio-Pharmaceutical General Manager & Chairman 000 0000
To view Royal Bio-Pharmaceutical’s complete board members history, request access »

Royal Bio-Pharmaceutical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Easttop Corporation Minority 000 0000 000000 0
Dongxu Investment Corporation Minority 000 0000 000000 0
Shenzhen GTJA Investment Group Venture Capital Minority 000 0000 000000 0
Xinyuan Assets Other Private Equity Minority 000 0000 000000 0
To view Royal Bio-Pharmaceutical’s complete investors history, request access »

Royal Bio-Pharmaceutical FAQs

  • When was Royal Bio-Pharmaceutical founded?

    Royal Bio-Pharmaceutical was founded in 2002.

  • Where is Royal Bio-Pharmaceutical headquartered?

    Royal Bio-Pharmaceutical is headquartered in Wuxi, China.

  • What industry is Royal Bio-Pharmaceutical in?

    Royal Bio-Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Royal Bio-Pharmaceutical a private or public company?

    Royal Bio-Pharmaceutical is a Private company.

  • What is Royal Bio-Pharmaceutical’s current revenue?

    The current revenue for Royal Bio-Pharmaceutical is 000000.

  • How much funding has Royal Bio-Pharmaceutical raised over time?

    Royal Bio-Pharmaceutical has raised $58.4M.

  • Who are Royal Bio-Pharmaceutical’s investors?

    Easttop, Dongxu Investment, Shenzhen GTJA Investment Group, and Xinyuan Assets have invested in Royal Bio-Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »